Study Evaluating the Effect of Jublia on Dermatophytomas

Status Completed

Clinical Trial Summary

This study will examine how Jublia affects dermatophytomas, which are difficult to treat with other therapeutic options.

Clinical Trial Description

Dermatophytomas are known to be resistant to even long courses of systemic antifungals, and have therefore been excluded from both topical and systemic clinical trials for onychomycosis, including those for Efinaconazole solution. Efinaconazole (Jublia) 10% solution is an FDA approved topical medication indicated for treatment of distal lateral subungual onychomycosis (DLSO), and the utility of this medication likely exceeds published results. Efinaconazole solution's novel ability to penetrate into the subungual space likely accounts for improved treatment results seen in DLSO treated with Jublia. We will investigate the utility of topical efinaconazole solution in the treatment of dermatophytomas. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03098615
Study type	Interventional
Source	University of Alabama at Birmingham
Contact
Status	Completed
Phase	Phase 4
Start date	September 2015
Completion date	July 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01666002` - Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser	N/A
Completed	`NCT01180491` - A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis	N/A
Terminated	`NCT01208168` - Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Phase 3
Terminated	`NCT01208129` - Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Phase 3
Completed	`NCT00385502` - A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail	Phase 2
Completed	`NCT00253305` - Topical Gel Anti-Fungal Agent for Tinea Unguium	Phase 2
Not yet recruiting	`NCT05809297` - Diode Laser and Photodynamic Therapy Vs. Ciclopirox.	Phase 4
Completed	`NCT03405818` - An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents	Phase 4
Completed	`NCT02588599` - A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis	N/A
Recruiting	`NCT02436291` - Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis	Phase 4
Completed	`NCT01851590` - Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis	Phase 4
Completed	`NCT01452490` - Diode Laser Treatment of Onychomycosis	N/A
Withdrawn	`NCT00938925` - Effectiveness of Podiatry Care on Onychomycosis (EPOCAON)	N/A
Recruiting	`NCT00808366` - Efficacy and Safety of RV4104A Ointment in Onychomycosis	N/A
Completed	`NCT00768768` - Iontophoretic Application of Terbinafine Gel to the Large Toe Nail	Phase 1
Completed	`NCT00781820` - Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste	Phase 3
Completed	`NCT00777868` - A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis	Phase 2
Recruiting	`NCT06074315` - Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis	N/A
Completed	`NCT01039883` - A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule	Phase 1
Suspended	`NCT05491603` - A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis	Phase 2